How to Sequence Target-Group Research Before You Field a Study
On this page
Before fielding a launch study, define the decision and required evidence, then choose how to resolve the remaining uncertainty. Baseline analysis, a human cognitive pilot, a modeled choice screen, and recruited or live validation can each have a role. A simulation screen is useful only when its grounding and expected decision value justify the added stage.
Put the launch decision before the audience profile
"Understand the customer" can be a useful discovery objective, but it does not yet specify the action a launch study should inform. Use exploratory work to refine the alternatives and outcomes where they remain unclear.
Start with the action that will change if the evidence changes. The decision might be choosing between two product concepts, selecting a message for a defined buyer segment, or deciding whether a pricing hypothesis is ready for a higher-stakes study. Name the alternatives, the target segment, the behavior that matters, and the evidence threshold for proceeding.
Pretesting can reveal unclear concepts before larger fielding. A small human pilot may resolve comprehension or population-grounding problems directly; compare that route with adding a simulation screen using actual recruitment conditions, quoted costs, and the decision deadline.
Choose the research stages the decision needs
1. Define the action and evidence threshold
Write the decision in a form that can be tested: "Which of these two concepts should advance for this segment?" is stronger than "What does this audience want?"
Set the evidence threshold at the same time. A directional screening decision, a representative population estimate, a regulatory claim, and a final pricing decision with real financial exposure do not require the same proof. The study plan should state which one it must support.
2. How do you establish the behavioral baseline?
Use existing market, customer, product, and behavioral data to define the starting conditions. This step can reveal who is already engaging, which segments matter to the decision, and where behavior differs.
A descriptive baseline helps define eligibility, alternatives, and current outcomes. It does not by itself identify an intervention effect. Use an appropriate comparison and identification assumptions for that question.
Plan baseline work and fielding from the actual data available, recruitment conditions, and evidence standard. A dated proposal should separate data preparation, pretesting, generation or recruitment, analysis, review, and contingencies.
3. Screen the hypotheses with controlled choices
Turn the remaining concepts, messages, or positioning options into structured alternatives. Discrete-choice modeling studies preferences by asking people to choose among alternatives described by different attributes (Displayr, "Discrete Choice Modeling: A Market Researcher's Guide").
If the population is adequately grounded, a controlled generated-choice screen can help compare defined alternatives before further study. For a Subconscious study, agree on assignment, endpoint, estimator, uncertainty assumptions, and independent checks. Set a conservative advancement rule, retain the status quo and borderline options, and use human checks on a sample of rejected options when the cost of a false negative warrants it.
4. Validate the response required for the decision
If generated and human results will be compared, align eligibility, alternatives, instrument, assignment, and endpoint where appropriate. Agree on recruited-human fielding separately and record differences. Do not assume screening only passing options will detect a model's false negatives.
A human hypothetical-choice task can evaluate choice-task fidelity. It does not automatically validate actual uptake. A live behavioral comparison may be needed when the launch decision depends on purchases, activation, or renewal.
Budget fielding around evidence, not activity
Compare a direct human pilot with a modeled screen plus validation using the uncertainty each route can resolve, recruitment feasibility, grounding quality, cost, and deadline.
| Planning question | Direct human pilot | Modeled screen plus validation |
|---|---|---|
| Main unresolved risk | Can inspect comprehension, lived experience, and task usability directly | Can explore structured alternatives when the generated population is grounded |
| Screening risk | A small pilot still has limited coverage and precision | Model mismatch can reject a real winner; retain borderline options and check rejected candidates where warranted |
| Budget and timing | Quote pilot and later fielding costs under actual recruitment conditions | Include grounding, screening, independent validation, and revision costs |
| Final evidence | Choose later sample and endpoint to match the decision | Validate the required endpoint rather than assume a passing screen proves market performance |
The appropriate sequence can differ by study. Record the reason for each stage and the criterion for advancing, revising, or stopping.
How do you match the method to the claim you need to make?
A controlled comparison addresses effects on its measured response. A generated-choice result alone does not establish representative market size, observed purchasing, or compliance with a requirement for human data. Verify the specific evidence needed for the intended claim.
Brain, Jadambaa, and Kularatna's 2022 scoping review examined 27 discrete-choice studies of cancer and cardiovascular screening preferences. That shows an application of structured preference research, not universal external validity or proof of actual screening uptake.
Do not turn uncertainty into a universal confidence-interval promise. Do not treat an audience-reach figure as a recruitable panel. Do not treat a ranked result as an automated decision. The research owner remains responsible for matching the evidence to the launch decision.
Bring one fieldable question to the research plan
Choose one upcoming launch decision. Write the alternatives, eligible population, intended response, and criteria for acting. Compare the available research routes, including a direct human pilot, and preserve options that uncertain screening results cannot safely eliminate.
Review the aggregate method evidence, then bring the decision, available data, recruitment constraints, and deadline to a study review to choose the evidence path.